Abstract
We have modelled multiple stages of malignant transformation of human endothelial cells (ECs) by overexpressing the catalytic subunit of human telomerase (hTERT), together with SV40 T antigen (SV40T) and oncogenic N-ras. Transfection with hTERT alone, led to the immortalization of two out of three cultures of bone marrow-derived ECs (BMECs). One hTERT transduced BMEC culture underwent a long proliferative lag before resuming proliferation. BMECs transfected with hTERT alone were functionally and phenotypically normal. BMECs transfected with SV40T (BMSVTs) had an extended lifespan, but eventually succumbed to crisis. BMSVTs exhibited a partially transformed phenotype, demonstrating growth factor independence, altered antigen expression and forming tiny, infrequent colonies in vitro. Transduction of BMSVTs with hTERT resulted in immortalization of 4 out of 4 cultures. BMSVTs immortalized with hTERT formed large colonies in vitro and small transient tumours in vivo. BMECs co-expressing SV40T, hTERT and N-ras exhibited an overtly transformed phenotype; forming very large colonies with an altered morphology and generating rapidly growing tumours in vivo. These investigations demonstrate transformation of human ECs to an overtly malignant phenotype. This model will be useful for understanding mechanisms underlying vascular and angiogenic neoplasias, as well as for testing drugs designed to curtail aberrant EC growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrejauskas E, Moroni C . 1989 EMBO J. 8: 2575–2581
Baumann P, Cech TR . 2001 Science 292: 1171–1175
Bergers G, Javaherian K, Lo K, Folkman J, Hanahan D . 1999 Science 284: 808–812
Blackburn EH . 2000 Nature 408: 53–55
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE . 1998 Science 279: 349–352
Bos JL . 1989 Cancer Res. 49: 4682–4689
Candal FJ, Rafii S, Parker JT, Ades EW, Ferris B, Nachman RL, Keller KL . 1996 Microvasc. Res. 52: 221–234
Couch V, Lindor NM, Karnes PS, Michels V . 2000 Mayo Clin. Proc. 75: 265–272
Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S . 1992 EMBO J. 11: 1921–1929
Counter CM, Hahn WC, Wei W, Dickinson Caddle S, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA . 1998 Proc. Natl. Acad. Sci. USA 95: 14723–14728
Dickinson MA, Hahn WC, Ino Y, Ronford V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG . 2000 Mol. Cell Biol. 20: 1436–1447
Drolet BA, Esterly NB, Frieden IJ . 1999 New England J. Med. 341: 173–181
Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA . 2001 Genes Dev. 15: 50–65
Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS . 1997 Blood 90: 182–193
Fearon ER, Vogelstein B . 1990 Cell 61: 759–767
Fickling SA, Tooze JA, Whitley GSJ . 1992 Exp. Cell. Res. 201: 517–521
Fox PL, Gaurisankar S, Dobrowolski SF, Stacey DW . 1994 Oncogene 9: 3519–3526
Franco S, MacKenzie KL, Dias S, Alvarez S, Rafii S, Moore MAS . 2001 Exp. Cell Res. 268: 14–25
Froment O, Boivin S, Barbin A, Bancel B, Trepo C, Marion MJ . 1994 Cancer Res. 54: 5340–5345
Gimbrone Jr MA, Fareed GC . 1976 Cell 9: 685–693
Girardi AJ, Jensen FC, Koprowski H . 1965 J. Cell. Comp. Physiol. 65: 69–84
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . 1999 Nature 400: 464–468
Halvorsen TL, Leibowitz G, Levine F . 1999 Mol. Cell. Biol. 19: 1864–1870
Harley CB, Futcher AB, Greider CW . 1990 Nature 345: 458–460
Hayflick L, Moorhead PS . 1961 Exp. Cell. Res. 25: 585–621
Hohenwarter O, Zinser E, Schmatz C, Ruker F, Katinger H . 1992 J. Biotech. 25: 349–356
Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP . 1999 Nat. Genet. 21: 111–114
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2014
Kim S, Kaminker P, Campisi J . 1999 Nat. Genet. 23: 405–312
Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ . 1998 Nature 396: 84–88
Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK . 1994 Mol. Cell. Biol. 14: 961–969
Land H, Parada LF, Weinberg RA . 1983 Science 222: 769–770
MacKenzie KL, Dolnikov A, Millington M, Shounan Y, Symonds G . 1999 Blood 93: 2043–2056
MacKenzie KL, Franco S, May C, Sadelain M, Moore MAS . 2000 Exp. Cell. Res. 259: 336–350
Maher J, Baker DA, Manning M, Dibb NJ, Roberts IA . 1995 Oncogene 11: 1639–1647
Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF . 1996 Cancer 77: 2400–2406
Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu J-R . 1988 Proc. Natl. Acad. Sci. USA 85: 6622–6626
O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver ARJ, Davies DC, Alsop AE, Neville AM, Jat PS . 2001 Proc. Natl. Acad. Sci. USA 98: 646–651
Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MAS, Rafii S . 2000 Blood 95: 952–958
Primo L, Roca C, Ferrandi C, Lanfrancone L, Bussolino F . 2000 Oncogene 19: 3632–3641
Pruitt K, Der CJ . 2001 Cancer Letters 171: 1–10
Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, Moore MAS, Asch AS . 1994 Blood 84: 10–19
Rak J, Mitshuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS . 1995 Cancer Res. 55: 4575–4580
Ramirez RD, Morales CP, Herbert B-S, Rohde JM, Passons C, Shay JW, Wright WE . 2001 Genes Dev. 15: 398–403
Rhim JS, Tsai WP, Chen ZQ, Van Waes C, Burger AM, Lautenberger JA . 1998 Carcinogenesis 19: 673–681
Scott-Taylor TH, Gallardo HF, Gansbacher B, Sadelain M . 1998 Gene Ther. 5: 621–629
Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD . 1984 Nature 312: 71–73
Shay JW, Pereira-Smith OM, Wright WE . 1991 Exp. Cell Res. 196: 33–39
Shay JW, Van Der Haegen BA, Ying Y, Wright WE . 1993 Exp. Cell. Res. 209: 45–52
Smith J, Pereira-Smith OM . 1996 Science 273: 63–66
Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB . 1994 J. Clin. Invest. 93: 2357–2364
van Steensel B, de Lange T . 1997 Nature 385: 740–743
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL . 1988 New Eng. J. Med. 319: 525–532
Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu C-P, Herron GS . 1999 J. Biol. Chem. 274: 26141–26148
Zhu J, Wang H, Bishop JM, Blackburn EH . 1999 Proc. Natl. Acad. Sci. USA 96: 3723–3728
Acknowledgements
This work was supported by NCI grant CA59350, NHLBI grant HL 61401 and the Gar Reichman Fund of Cancer Research Institute. We thank Ms Dianna Ngok, Mr Jason Anselmo, Mr Sheik Baksh and Mr Harry Satterwaite for technical assistance, Mr George Nam for preparation of ECGM and EC isolation. We thank Geron Corporation for the hTERT cDNA and Imclone Systems Incorporated for antibodies to VEGF receptors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
MacKenzie, K., Franco, S., Naiyer, A. et al. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene 21, 4200–4211 (2002). https://doi.org/10.1038/sj.onc.1205425
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205425
Keywords
This article is cited by
-
Establishment and characterization of immortalized porcine neonatal hepatocytes without the use of viral components
In Vitro Cellular & Developmental Biology - Animal (2020)
-
A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration
Cell & Bioscience (2019)
-
Establishment, characterization, and toxicological application of a spontaneous immortalized cell line from the striped field mouse, Apodemus agrarius
In Vitro Cellular & Developmental Biology - Animal (2018)
-
Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder
Journal of Translational Medicine (2017)
-
New prospects for targeting telomerase beyond the telomere
Nature Reviews Cancer (2016)